Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL31196404

COC(=O)C1(C)CC(N)C1.O=C(O)C(F)(F)F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21576490 0.87 NPSR1 (0.33)
SCHEMBL25554244 0.87 NPSR1 (0.33)
SCHEMBL20690392 0.87 NPSR1 (0.33)
Hydrochloric Acid SCHEMBL21570151 0.85 NPSR1 (0.32)
SCHEMBL30234161 0.75 ATM (0.33)
SCHEMBL20285870 0.73 NPSR1 (0.34)
SCHEMBL21496929 0.73 MEN1 (0.32)
SCHEMBL2340414 0.73 NPSR1 (0.33)
SCHEMBL2340412 0.73 NPSR1 (0.33)
SCHEMBL17064244 0.73 NPSR1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709716-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 EP disclosed
WO-2024233554-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2024-11-14 WO disclosed